Literature DB >> 10449609

Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.

A Anttila1, E Pukkala, B Söderman, M Kallio, P Nieminen, M Hakama.   

Abstract

A nation-wide screening programme for cervical cancer started in Finland gradually from 1963 onwards. By the beginning of the 1990s, there had been a decrease of 80% both in the age-adjusted incidence of and mortality from cervical cancer. To describe the recent patterns in cervical cancer incidence and mortality and evaluate their differentials in relation with the organised screening activities, we have updated the material on the cervical cancer incidence and mortality as well as mass-screening activities up to the year 1995. Based on the files of the Finnish Cancer Registry, there is a striking increase of about 60% in the incidence of cervical cancer during the last 4 years of the study period among women below 55 years of age. The mortality rates are still decreasing. There is no overall decrease over recent years in the coverage of the programme invitations or smears taken. Incidence of invasive cancer and of moderate and severe dysplasia as detected in mass screening have increased. As to the interpretation, changes in the risk factors, such as in sexual behaviour and smoking habits, over the decades might partly explain increasing trends in cervical cancer incidence. As the change in incidence was relatively abrupt, inadequacies or changes in the effectiveness in the screening programme, particularly among young women, may also have contributed. Expanding the coverage of and attendance in the pap-screening programme among women in young target ages would still be effective. Increasing emphasis on quality assessment in screening is also needed. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10449609     DOI: 10.1002/(sici)1097-0215(19990924)83:1<59::aid-ijc12>3.0.co;2-n

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Age-incidence relationships and time trends in cervical cancer in Sweden.

Authors:  K Hemminki; X Li; P Mutanen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

Authors:  S Bulk; F J Van Kemenade; L Rozendaal; C J L M Meijer
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

3.  Turkish Ministry of Health, 2nd Turkish Medical General Assembly Clinical Oncology Study Group Report.

Authors:  Vahit Özmen; Nergiz Dağoğlu; İsmet Dede; Adem Akçakaya; Mustafa Kerem; Fatih Göksel; Enver Özgür; Emel Başkan; Mustafa Yaylacı; Adil Ceydeli; Meltem Baykara; Huriye Şenay Kızıltan; Şeref Kömürcü; Mahmut Gümüş; H Mehmet Türk; Recep Demirhan; Ali Akgün; Naim Kadoglou; Emre Yatman; Cem Cüneyt Elbi; Seza Güleç; Atilla Soran; Ahmet Özet; Fahrettin Keleştimur
Journal:  J Breast Health       Date:  2016-01-01

4.  Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.

Authors:  C Popadiuk; C L Gauvreau; M Bhavsar; C Nadeau; K Asakawa; W M Flanagan; M C Wolfson; A J Coldman; S Memon; N Fitzgerald; J Lacombe; A B Miller
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

5.  Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer.

Authors:  Goel Madhumati; Somani Kavita; Mehrotra Anju; Singh Uma; Mehrotra Raj
Journal:  J Obstet Gynaecol India       Date:  2012-10-09

6.  Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia.

Authors:  Alice Kivistik; Katrin Lang; Paolo Baili; Ahti Anttila; Piret Veerus
Journal:  BMC Womens Health       Date:  2011-09-28       Impact factor: 2.809

7.  Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.

Authors:  Ruanne V Barnabas; Päivi Laukkanen; Pentti Koskela; Osmo Kontula; Matti Lehtinen; Geoff P Garnett
Journal:  PLoS Med       Date:  2006-04-04       Impact factor: 11.069

8.  Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.

Authors:  Peter Sasieni; Alejandra Castanon; Jack Cuzick
Journal:  BMJ       Date:  2009-07-28

9.  Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.

Authors:  Mirte Scherpenisse; Madelief Mollers; Rutger M Schepp; Hein J Boot; Chris J L M Meijer; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

10.  Monitoring the profile of cervical cancer in a developing city.

Authors:  Fábio Marques de Almeida; José Carlos de Oliveira; Edésio Martins; Maria Paula Curado; Ruffo de Freitas; Marise Amaral Rebouças Moreira
Journal:  BMC Public Health       Date:  2013-06-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.